Search

Search Results

1. Induction of phase I, II and III drug metabolism/transport by xenobiotics

   Drug metabolizing enzymes (DMEs) play central roles in the metabolism, elimination and detoxification of xenobiotics and drugs introduced into the...

   Changjiang Xu, Christina Yong-Tao Li, Ah-Ng Tony Kong in Archives of Pharmacal Research

   Article 01 March 2005

2. Hormone therapy: association with dementia in women?

   in Inpharma Weekly

   Article 01 July 2004

3. Donepezil enhances cognitive function, QOL in AD

   in Inpharma Weekly

   Article 01 May 2004

4. Donepezil in vascular dementia: profile report

   David S. Geldmacher, Gustavo C. Román, Sandra E. Black in Drugs & Therapy Perspectives

   Article 01 April 2004
   

5. Nicotiana tabacum

   Nicotiana tabacum is a stout annual of the TOMENTOSAE family, approx 1–3 m high. The stem is erect with few branches. Leaves are...

   in Medicinal Plants of the World, Volume 3

   Chapter 2005
   

6. Rivastigmine leads to clinically relevant QOL improvement

   in Inpharma Weekly

   Article 01 January 2004

7. Antidementiva

   Cholinesterasehemmer haben nach einem erneuten kräftigen Verordnungszuwachs einen Anteil von 10% am Verordnungsvolumen der Antidementiva nach...

   Ulrich Schwabe in Arzneiverordnungs-Report 2004

   Chapter 2004
   

8. Management of Mild to Moderate Alzheimer Disease

   Alzheimer disease is a common, progressive neurodegenerative disorder of the elderly, affecting approximately 3% of individuals 65–74 years of age,...

   Greg L. Plosker, Gillian M. Keating in Disease Management & Health Outcomes

   Article 01 January 2004
   

9. Donepezil + tocopherol beneficial in AD

   in Inpharma Weekly

   Article 01 August 2003

10. Health Screening and Health Promotion Programs for the Elderly

    As the population of elderly people worldwide continues to grow, successful aging has risen to the top of the health policy agenda. The definition of...

    Adam Drewnowski, Elaine Monsen, ... Gillian Marshall in Disease Management & Health Outcomes

    Article 01 May 2003
    

11. Memantine improves outlook, cuts healthcare costs in AD

    in Inpharma Weekly

    Article 01 July 2003

12. Aspirin, vitamins improve markers of cognitive function

    in Inpharma Weekly

    Article 01 July 2003

13. Long-Term Effects of Second-Generation Cholinesterase Inhibitors on Clinical Outcomes and Costs of Alzheimer’s Disease

    Alzheimer’s disease, which is a common disorder among the elderly, not only has devastating health consequences, but also poses a substantial...

    J. Jaime Caro, Denis Getsios in Disease Management & Health Outcomes

    Article 01 October 2003
    

14. Galantamine: dual mechanism advantageous in dementia

    in Inpharma Weekly

    Article 01 May 2003

15. HRT: increased risk of dementia and stroke

    in Inpharma Weekly

    Article 01 June 2003

16. Donepezil beneficial across the dementia spectrum

    in Inpharma Weekly

    Article 01 May 2003

17. Dronabinol may reduce agitation and improve appetite in Alzheimer's disease

    in Inpharma Weekly

    Article 01 May 2003

18. Minocycline beneficial in Huntington's disease

    in Inpharma Weekly

    Article 01 April 2003

19. Cognitive dysfunction is a considerable, yet under-recognised, problem in patients with multiple sclerosis

    in Drugs & Therapy Perspectives

    Article 01 May 2003

20. `Cerebrolysin' effective in acute ischaemic stroke

    in Inpharma Weekly

    Article 01 December 2002